10x Genomics Inc (NAS:TXG)
$ 23.95 -0.88 (-3.54%) Market Cap: 2.87 Bil Enterprise Value: 2.69 Bil PE Ratio: 0 PB Ratio: 4.13 GF Score: 75/100

Q4 2019 10X Genomics Inc Earnings Call Transcript

Feb 18, 2020 / 09:30PM GMT
Release Date Price: $90.22 (-2.54%)
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the 10x Genomics Fourth Quarter Earnings Conference.

(Operator Instructions)

Please be advised that today's conference is being recorded.

(Operator Instructions)

I would now like to hand the conference over to your speaker, Ms. Carrie Mendivil with Investor Relations. Please go ahead.

Carrie Mendivil
Gilmartin Group LLC - Principal

Thank you. Earlier today, 10x Genomics released financial results for the quarter and year ended December 31, 2019. If you have not received this news release or if you'd like to be added to the company's distribution list, please send an e-mail to [email protected]. An archived webcast of this call will be available on the Investor tab of the company's website, 10xgenomics.com, for the next -- for at least the next 45 days following this call.

Before we begin, I'd like to remind you that management will make statements during this call that are forward-looking statements within the meaning of federal securities

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot